FDA Import Refusal 799-4641353-1/11/3 — CADILA PHARMA LTD
The FDA refused shipment 799-4641353-1/11/3 from CADILA PHARMA LTD (India) on May 4, 2023. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- May 4, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCB14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 75